Aberrant Level of Skp2 and p27KIP1 in Intraductal Proliferative Lesions is Associated with Tumorigenesis

References

• Tavassoli FA, Hoefler H, Rosai J, Holland R, Ellis IO, Schnitt S. Intraductal Proliferative Lesions. In: Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs (World Health Organization Classification of Tumors). 1st ed. Lyon, France: International Agency for Research on Cancer (IARC) Press; 2003, pp. 63–73.
   Google Scholar
• Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. WHO classification of tumors of breast. World Health Orgnization Classification of Tumors [M]. 4th ed. Lyon: IARC Press; 2012.
   Google Scholar
• Sinn H-P, Elsawaf Z, Helmchen B, Aulmann S. Early breast cancer precursor lesions: lessons learned from molecular and clinical studies. Breast Care (Basel). 2010;5(4):218–226.
   PubMed Web of Science ®Google Scholar
• Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 1999;13(9):1181–1189.
   PubMed Web of Science ®Google Scholar
• Frescas D, Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat Rev Cancer. 2008 Jun;8(6):438–449.
   PubMed Web of Science ®Google Scholar
• Pavlides SC, Huang K-T, Reid DA, Wu L, Blank SV, Mittal K, et al. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27KIP1: therapeutic potential for endometrial cancer. Endocrinology. 2013;154(11):4030–4045.
   PubMed Web of Science ®Google Scholar
• Kim J-Y, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI. Epidermal growth factor upregulates Skp2/Cks1 and p27KIP1 in human extrahepatic cholangiocarcinoma cells. World J Gastroenterol. 2014;20(3):755–773.
   PubMed Web of Science ®Google Scholar
• Carrano AC, Pagano M. Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol. 2001;153(7):1381–1390.
   PubMed Web of Science ®Google Scholar
• Signoretti S, Marcotullio LD, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 2002 Sep 1;110(5):633–641.
   PubMed Web of Science ®Google Scholar
• Mirchandani D, Roses DF, Inghirami G, Zeleniuch-Jacquotte A, Cangiarella J, Guth A, et al. Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma. Anticancer Res. 2011 Dec;31(12):4401–4405.
   PubMed Web of Science ®Google Scholar
• Xu D, Li C-F, Zhang X, Gong Z, Chan CH, Lee SW, et al. Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition, polyploidy and tumourigenesis. Nat Commun. 2015;6:6641–74.
   PubMed Web of Science ®Google Scholar
• Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R. Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat 2006; 99: 185–191.
   PubMed Web of Science ®Google Scholar
• Degnim AC, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007;25(19):2671–2677.
   PubMed Web of Science ®Google Scholar
• Ling YH, Li T, Yuan Z, Haigentz M Jr., Weber TK, Perez-Soler R. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines. Mol Pharmacol. 2007;72(2):248–58.
   PubMed Web of Science ®Google Scholar
• Keikhaee MR, Kudo Y, Siriwardena S, Wu L, Ogawa I, Takata T, et al. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma. Virchows Arch. 2007; 450(5):567–74.
   PubMed Web of Science ®Google Scholar
• Kim J-Y, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, et al. Epidermal growth factor upregulates Skp2/Cks1 and p27KIP1 in human extrahepatic cholangiocarcinoma cells. World J Gastroenterol. 2014;20(3):755–773.
   PubMed Web of Science ®Google Scholar
• Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, et al. p27 phosphorylation by Src regulates inhibition of Cyclin E-Cdk2 and p27 proteolysis. Cell. 2007;128(2):281–294.
   PubMed Web of Science ®Google Scholar
• Said SM, Visscher DW, Nassar A, Frank RD, Vierkant RA, Frost MH, et al. Flat epithelial atypia and risk of breast cancer: a Mayo cohort study. Cancer. 2015;121(10):1548–1555.
   PubMed Web of Science ®Google Scholar
• Piubello Q, Parisi A, Eccher A, Barbazeni G, Franchini Z, Iannucci A. Flat epithelial atypia on core needle biopsy: which is the right management? Am J Surg Pathol 2009;33:1078–1084.
   PubMed Web of Science ®Google Scholar
• Hartmann LC, Sellers TA, Frost MH, Hassell PR, Hayes MM, van Niekerk D, et al. Benign breast lesions and the risk of breast cancer. N Engl J Med 2007;353(3):229–237.
   Web of Science ®Google Scholar
• Becker AK, Gordon PB, Harrison DA, Hassell PR, Hayes MM, van Niekerk D, et al. Flat ductal intraepithelial neoplasia 1A diagnosed at stereotactic core needle biopsy: is excisional biopsy indicated? AJR Am J Roentgenol 2013;200:682–688.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Stender JD, Joshi S, Wu G, Katzenellenbogen BS. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells. Oncogene. 2016;35(44):5722–5734.
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest. 2007;117(12):3765–73.
   PubMed Web of Science ®Google Scholar